BIO-TECHNE Corp Effective Tax Rate
BIO-TECHNE Corp (TECH) reported Effective Tax Rate of 24.40% for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-24
- BIO-TECHNE Corp effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 28.30%, a 30.98% decline year-over-year.
- BIO-TECHNE Corp effective income tax rate reconciliation, percent for the quarter ending 2025-12-31 was 25.20%, a 35.48% increase year-over-year.
- BIO-TECHNE Corp effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 20.40%, a 24.39% increase year-over-year.
- BIO-TECHNE Corp effective income tax rate reconciliation, percent for the quarter ending 2025-03-31 was 41.00%, a 108.12% increase year-over-year.
- BIO-TECHNE Corp effective income tax rate reconciliation, percent for fiscal 2026 was 24.40%, a 4.31% decline from fiscal 2025.
- BIO-TECHNE Corp effective income tax rate reconciliation, percent for fiscal 2025 was 25.50%, a 168.42% increase from fiscal 2024.
- BIO-TECHNE Corp effective income tax rate reconciliation, percent for fiscal 2024 was 9.50%, a 39.49% decline from fiscal 2023.
- BIO-TECHNE Corp effective income tax rate reconciliation, percent for fiscal 2023 was 15.70%, a 23.62% increase from fiscal 2022.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 9 month as first filed | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 24.40% 10-K · filed 2026-08-24 | ||||||
| 2026-03-31 | 28.30% 10-Q · filed 2026-05-06 | 25.20% 10-Q · filed 2026-05-06 | |||||
| 2025-12-31 | 25.20% 10-Q · filed 2026-02-04 | 22.90% 10-Q · filed 2026-02-04 | |||||
| 2025-09-30 | 20.40% 10-Q · filed 2025-11-05 | ||||||
| 2025-06-30 | 25.50% 10-K · filed 2026-08-24 | ||||||
| 2025-03-31 | 41.00% 10-Q · filed 2026-05-06 | 24.90% 10-Q · filed 2026-05-06 | |||||
| 2024-12-31 | 18.60% 10-Q · filed 2026-02-04 | 17.50% 10-Q · filed 2026-02-04 | |||||
| 2024-09-30 | 16.40% 10-Q · filed 2025-11-05 | ||||||
| 2024-06-30 | 9.50% 10-K · filed 2026-08-24 | ||||||
| 2024-03-31 | 19.70% 10-Q · filed 2025-05-08 | 11.50% 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | 17.70% 10-Q · filed 2025-02-06 | 5.40% 10-Q · filed 2025-02-06 | |||||
| 2023-09-30 | -2.90% 10-Q · filed 2024-11-05 | ||||||
| 2023-06-30 | 15.70% 10-K · filed 2025-08-22 | ||||||
| 2023-03-31 | 12.40% 10-Q · filed 2024-05-06 | 16.10% 10-Q · filed 2024-05-06 | |||||
| 2022-12-31 | 24.70% 10-Q · filed 2024-02-07 | 17.90% 10-Q · filed 2024-02-07 | |||||
| 2022-09-30 | 13.50% 10-Q · filed 2023-11-07 | ||||||
| 2022-06-30 | 12.70% 10-K · filed 2024-08-22 | ||||||
| 2022-03-31 | 12.50% 10-Q · filed 2023-05-08 | 9.50% 10-Q · filed 2023-05-08 | |||||
| 2021-12-31 | 16.40% 10-Q · filed 2023-02-07 | 8.20% 10-Q · filed 2023-02-07 | |||||
| 2021-09-30 | -2.40% 10-Q · filed 2022-11-07 | ||||||
| 2021-06-30 | 5.80% 10-K · filed 2023-08-23 | ||||||
| 2021-03-31 | -0.10% 10-Q · filed 2022-05-09 | 11.40% 10-Q · filed 2022-05-09 | |||||
| 2020-12-31 | 18.10% 10-Q · filed 2022-02-07 | 16.90% 10-Q · filed 2022-02-07 | |||||
| 2020-09-30 | 15.10% 10-Q · filed 2021-11-08 | ||||||
| 2020-06-30 | 17.10% 10-K · filed 2022-08-24 | ||||||
| 2020-03-31 | 22.20% 10-Q · filed 2021-05-07 | 20.70% 10-Q · filed 2021-05-07 | |||||
| 2019-12-31 | 20.40% 10-Q · filed 2021-02-08 | 20.30% 10-Q · filed 2021-02-08 | |||||
| 2019-09-30 | 19.10% 10-Q · filed 2020-11-09 | ||||||
| 2019-06-30 | 14.20% 10-K · filed 2021-08-25 | ||||||
| 2019-03-31 | 10.50% 10-Q · filed 2020-05-11 | 10.80% 10-Q · filed 2020-05-11 | |||||
| 2018-12-31 | 19.30% 10-Q · filed 2020-02-06 | -19.30% 10-Q · filed 2019-02-07 | 11.20% 10-Q · filed 2020-02-06 | -11.20% 10-Q · filed 2019-02-07 | |||
| 2018-09-30 | 1.00% 10-Q · filed 2019-11-06 | ||||||
| 2018-06-30 | -0.20% 10-K · filed 2020-08-26 | ||||||
| 2018-03-31 | 21.00% 10-Q · filed 2019-05-07 | -21.20% 10-Q · filed 2019-05-07 | |||||
| 2017-12-31 | -124.80% 10-Q · filed 2019-02-07 | -124.70% 10-Q · filed 2018-02-08 | -44.80% 10-Q · filed 2019-02-07 | ||||
| 2017-09-30 | 30.90% 10-Q · filed 2018-11-07 | ||||||
| 2017-06-30 | 32.00% 10-K/A · filed 2019-11-06 | ||||||
| 2017-03-31 | 28.80% 10-Q · filed 2018-05-09 | 34.60% 10-Q · filed 2018-05-09 | 35.00% 10-Q · filed 2017-05-10 | ||||
| 2016-12-31 | 50.80% 10-Q · filed 2018-02-08 | 53.40% 10-Q · filed 2017-02-09 | 38.80% 10-Q · filed 2018-02-08 | 40.00% 10-Q · filed 2017-02-09 | |||
| 2016-09-30 | 32.20% 10-Q · filed 2017-11-09 | ||||||
| 2016-06-30 | 29.20% 10-K · filed 2018-08-27 | ||||||
| 2016-03-31 | 28.70% 10-Q · filed 2017-05-10 | 28.10% 10-Q · filed 2017-05-10 | |||||
| 2015-12-31 | 26.90% 10-Q · filed 2017-02-09 | 27.80% 10-Q · filed 2017-02-09 | |||||
| 2015-03-31 | 37.30% 10-Q · filed 2015-05-11 | 29.80% 10-Q · filed 2015-05-11 | |||||
| 2014-12-31 | 22.00% 10-Q · filed 2015-02-09 | 26.00% 10-Q · filed 2015-02-09 | |||||
| 2014-03-31 | 31.30% 10-Q · filed 2015-05-11 | 31.00% 10-Q · filed 2015-05-11 | |||||
| 2013-12-31 | 30.80% 10-Q · filed 2015-02-09 | 30.80% 10-Q · filed 2015-02-09 | |||||
| 2013-03-31 | 25.50% 10-Q · filed 2013-05-10 | 29.80% 10-Q · filed 2013-05-10 | |||||
| 2012-03-31 | 26.50% 10-Q · filed 2013-05-10 | 30.00% 10-Q · filed 2013-05-10 | |||||
| 2011-03-31 | 31.60% 10-Q · filed 2012-05-10 | 31.20% 10-Q · filed 2012-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |